MHC Haplotyping of SARS-CoV-2 Patients: HLA Subtypes Are Not Associated with the Presence and Severity of COVID-19 in the Israeli Population. All Authors: Author Profiles: Publish Date: Journal: , Read Publication
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. All Authors: Author Profiles: Publish Date: Journal: , Read Publication
Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. All Authors: Author Profiles: Publish Date: Journal: , Read Publication
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. All Authors: Author Profiles: Publish Date: Journal: , Read Publication
Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents. All Authors: Author Profiles: Publish Date: Journal: , Read Publication
Adverse Effects after BNT162b2 Vaccine and SARS-CoV-2 Infection, According to Age and Sex. All Authors: Author Profiles: Publish Date: Journal: , Read Publication
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. All Authors: Author Profiles: Publish Date: Journal: , Read Publication
The association between real-time reverse transcriptase polymerase chain reaction cycle threshold values, symptoms and disease severity among COVID-19 patients in the community: a retrospective cohort study. All Authors: Author Profiles: Publish Date: Journal: , Read Publication
Previously undiagnosed cancer in patients with arterial thrombotic events - A population-based cohort study. All Authors: Author Profiles: Publish Date: Journal: , Read Publication
Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI). All Authors: Author Profiles: Publish Date: Journal: , Read Publication
